For research use only. Not for therapeutic Use.
DABMA (Cat No.:I025493) is a small organic compound that has been studied for its potential biological and pharmacological applications. It features a thiazole ring and amino groups, which make it a candidate for interactions with various enzymes and receptors involved in cellular signaling. Research on DABMA has primarily focused on its role in modulating key biological processes, such as cell growth, inflammation, and oxidative stress. Although its precise therapeutic applications are still under investigation, DABMA may have potential in areas like cancer therapy, neuroprotection, or as a biochemical tool in pharmacological studies.
| Catalog Number | I025493 |
| Synonyms | DABMA |
| Molecular Formula | C20H28BrNO |
| Purity | 98% |
| Solubility | Soluble in DMSO |
| Appearance | Solid powder |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| IUPAC Name | N-[(5-bromo-2-methoxyphenyl)methyl]-3,5-dimethyladamantan-1-amine |
| InChI | InChI=1S/C20H28BrNO/c1-18-7-14-8-19(2,11-18)13-20(9-14,12-18)22-10-15-6-16(21)4-5-17(15)23-3/h4-6,14,22H,7-13H2,1-3H3 |
| InChIKey | BMSKZYQEVKGOFK-UHFFFAOYSA-N |
| SMILES | CC12CC3CC(C1)(CC(C3)(C2)NCC4=C(C=CC(=C4)Br)OC)C |
